NCT06512974 · NeuroTrainer
NeuroTrainer Cognitive Training For Academic Focus
What this study is about
This clinical trial aims to evaluate the feasibility and effectiveness of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
View original scientific description
This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Interventions
BEHAVIORAL
NeuroTrainer
Virtual reality based cognitive training
Primary outcome measures
NIH Toolbox Flanker Inhibitory Control and Attention Test (RT)
Time frame: Week 1, Month 2, Month 3, Month 9
This test is designed to evaluate an individual's ability to concentrate their attention while inhibiting automatic response tendencies that could potentially hinder goal achievement. The assessment has demonstrated changes in ADHD cases (Buzy, et al., 2009) and may be sensitive to treatment effects (Epstein et al., 2011). The test will take approximately 3 minutes to complete. This is the reaction time (RT) outcome from this assessment.
NIH Toolbox Flanker Inhibitory Control and Attention Test (IIV-RT)
Time frame: Week 1, Month 2, Month 3, Month 9
This test is designed to evaluate an individual's ability to concentrate their attention while inhibiting automatic response tendencies that could potentially hinder goal achievement. The assessment has demonstrated changes in ADHD cases (Buzy, et al., 2009) and may be sensitive to treatment effects (Epstein et al., 2011). The test will take approximately 3 minutes to complete. This is the intraindividual variability of RT (IIV-RT) outcome from this assessment.
NIH Toolbox Flanker Inhibitory Control and Attention Test (% Correct)
Time frame: Week 1, Month 2, Month 3, Month 9
This test is designed to evaluate an individual's ability to concentrate their attention while inhibiting automatic response tendencies that could potentially hinder goal achievement. The assessment has demonstrated changes in ADHD cases (Buzy, et al., 2009) and may be sensitive to treatment effects (Epstein et al., 2011). The test will take approximately 3 minutes to complete. This is the percent correct outcome from this assessment.
NIH Toolbox Dimensional Change Card Sort Test (% Correct)
Time frame: Week 1, Month 2, Month 3, Month 9
This test aims to measure an individual's capacity to switch between multiple aspects of a strategy or task. The test takes approximately 4 minutes to complete. This is the percent correct outcome from this assessment.
NIH Toolbox Dimensional Change Card Sort Test (Omissions)
Time frame: Week 1, Month 2, Month 3, Month 9
This test aims to measure an individual's capacity to switch between multiple aspects of a strategy or task. The test takes approximately 4 minutes to complete. This is the omissions outcome from this assessment.
NIH Toolbox Dimensional Change Card Sort Test (RT)
Time frame: Week 1, Month 2, Month 3, Month 9
This test aims to measure an individual's capacity to switch between multiple aspects of a strategy or task. The test takes approximately 4 minutes to complete. This is the response time (RT) outcome from this assessment.
NIH Toolbox Dimensional Change Card Sort Test (IIV-RT)
Time frame: Week 1, Month 2, Month 3, Month 9
This test aims to measure an individual's capacity to switch between multiple aspects of a strategy or task. The test takes approximately 4 minutes to complete. This is the intraindividual variability of RT (IIV-RT) outcome from this assessment.
NIH Toolbox List Sorting Working Memory Test
Time frame: Week 1, Month 2, Month 3, Month 9
This test serves as an evaluation of an individual's working memory capabilities. Participants will be presented with different stimuli visually and audibly, and they will be asked to recall and sequence them accordingly. The test takes approximately 7 minutes to complete.
NIH Toolbox Pattern Comparison Processing Speed Test
Time frame: Week 1, Month 2, Month 3, Month 9
This is an assessment of processing speed. Participants are asked to quickly determine whether two stimuli are the same or not the same. The test takes approximately 4 minutes to complete.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe
- Estimated IQ of 80 or greater
- Between 11-17 years of age
Exclusion criteria
- Presence of suicidality
- Presence of psychotic disorders
- Visual or hearing impairment
- Presence of severe depression
Where
- Marquette, Michigan
- Omaha, Nebraska
- Madison, Wisconsin
Collaborators
National Institute of Mental Health (NIMH), University of California, Davis
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 19, 2025 · Source of record for eligibility and locations